$121.73
+0.600 (+0.495%)
At Close: Jun 03, 2026
Why It Might Be Time To Pay Attention To These 4 Red-Hot Health Stocks
08:15am, Friday, 13'th Nov 2020
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
Why Shares of Repligen Soared in October
09:17am, Friday, 06'th Nov 2020
The bioprocessing technology company is having a great year.
Repligen Stock: This Little-Known Biotech Posts Record Results
05:15pm, Thursday, 05'th Nov 2020
Repligen stock jumped 9% on the heels of the report to a new 52-week high of $203.90 today. And Louis Navellier sees a lot more upside for the company.
Repligen Corporation's (RGEN) CEO Tony Hunt on Q3 2020 Results - Earnings Call Transcript
03:23pm, Thursday, 05'th Nov 2020
Repligen Corporation's (RGEN) CEO Tony Hunt on Q3 2020 Results - Earnings Call Transcript
WALTHAM, Mass., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into a
Sign In
Buy RGEN